Found 1,117 investors
Growth Factor BioCapital
Spain
Founded in 2013, Growth Factor Biocapital is a venture capital firm based in Madrid, Spain. The firm prefers to invest in early-stage and growth-stage companies. The firm seeks investments in the biotechnology industry based in Spain.
Venture Capital
Gruender Motor
United States
Dr. Richard Klausner is a Co-Founder and serves as the Chairman at LifeMine. He is a Co-Founder and serves as Chief Scientist & Chairman at Atlos Labs. He is the Founder and serves as the Executive Chairman & Board Member at Lyell. He is a Co-Founder and serves as the Executive Chairman at Mindstrong. He serves as Chairman at Sonoma Biotherapeutics. He serves as Board Member and Advisor at Orca Bio. Previously, he served as Chief Executive Officer and Board Member at Lyell. Dr. Richard Klausner is a Co-Founder & serves as Board Member at Juno Therapeutics. He served as the Chief Medical Officer & Senior Vice President at Illumina. He is a Scientific Advisor at Aragon Pharmaceuticals. He serves as a Board Member and Scientific Advisor at Grail (Biotechnology). He is the former Executive Director for Global Health of the Bill and Melinda Gates Foundation. Dr. Klausner was a Board Member at Audax. He was the eleventh director of the National Cancer Institute between 1995 and 2001. His research has been recognized with awards including the Outstanding Investigator Award from the American Federation of Clinical Research and the William Damashek Prize for major discoveries in hematology. He received the 1997-1998 Dickson Prize in Medicine and the 1998 Raymond Bourgine Award. He has served as an Advisor to the Presidents of the Academies for Counter-terrorism and Liaison to the White House Office of Science & Technology Policy. He is a member of the National Academy of Sciences, the Institute of Medicine, and the American Academy of Arts and Sciences. Dr. Klausner is a past president of the American Society of Clinical Investigation and has been Chairman of the National Science Education Standards Projects of the National Academy of Sciences. He previously served as the Chief Medical Officer and Senior Vice President at The Column Group. Dr. Klausner currently chairs the International Advisory Board for Samsung, is the Chairman of Audax Health, and previously chaired the Strategic Oversight Council of Sanofi. He is a member of the National Academy of Sciences, the Institute of Medicine, and the American Academy of Arts and Sciences. Dr. Klausner holds an M.D. from Duke Medical School. He serves as Chairman at Xtremity.
Individual/Angel
Grünwald Equity Management
Germany
Founded in 2001, Grünwald Equity Management is a private equity firm based in Grünwald, Germany. The firm prefers to invest in medium-sized companies across all sectors in the manufacturing, retail and services industries. Additionally, the firm invests in the origination and development of geothermal energy power plants located in Germany. The firm does not invest in biotech, complex software development, real estate, and commodity exploration sectors as well as highly regulated industries.
Private Equity Firm
Grupo Genetrix
Madrid, Madrid, Spain
Genetrix, created to promote entrepreneurial leaders in the biotechnology sector, is a group of companies aimed at generating value from
Biotechnology
Health Care
Medical
Venture Capital
Guangdong Highsun Group
China
Guangdong Highsun Group has launched a private equity fund to invest in the entertainment and internet of things (IoT) sectors in China. The firm will also make investment in public equity (PIPE) deals in China's domestic stock exchanges.
Private Equity Firm
GUB Management
Germany
GUB Management is a venture capital investment firm that is based in Schwäbisch Hall, Germany. The firm was incorporated in 1994 and prefers to invest in young high-technology companies operating in the healthcare, medical, renewable energy, biotechnology and information technology sectors.
Venture Capital
Guibert Englebienne
India
Mr. Hitesh Windlass is a Co-Founder and serves as Director at Windlas Biotech. Mr. Hitesh Windlass is an IIT graduate with MS and MBA degrees from Georgia Tech and University of Chicago. He has fourteen inventions and eight patents to his credit in US.
Individual/Angel
Guizhou Ventures Capital
China
Founded in 1998, Guizhou Ventures Capital is a Guizhou province state-owned venture capital firm based in Guizhou, China. The firm seeks to make investments in traditional industrial and High-tech industries such as materials, advanced manufacturing, SaaS, Hardware, and biotechnology.
Venture Capital
GVP Global
United States
GVP Global Corp is a private equity management firm that seeks to invest in the nanotechnology and robotics, diagnostic technologies and devices, innovative biotech drug discovery, data storage and cyber security. The firm was founded in 1994 and is headquartered in Boston, Massachusetts.
Private Equity Firm
Gyeongnam Venture Investment
South Korea
Founded in 2019, Gyeongnam venture investment is a venture capital investment firm based in Gyeongsangnam-Do, South Korea. The firm prefers to invest in the internet, communication, IoT, electricity, electronics, semiconductors, materials, automobiles, healthcare, biotechnology, cultural contents such as movies, performances, musicals and other industries with growth potential sectors.
Venture Capital
Hamraj Kumar
Italy
Mr. Harald Oberrauch serves as Vice-President of the Board at Covision Lab. He is the Founder & Owner of Tyrolean Business Angel. Mr. Harald Oberrauch serves as Board Observer at Immagina Biotechnology. He is also an Angel Investor. He is also President of Durst Group AG, President of Alupress AG and Founder of TBA - Tyrolean Business Angel.
Individual/Angel
Hanhai Investment
United States
Hanhai Investment provides an incubator and accelerator platform to high-tech entrepreneurs in the United States. It seeks to invest in the internet, semiconductor, big data, cyber security, internet of things (IoT), artificial intelligence, medical devices, robotics and new materials sectors. The firm facilitates the collaboration between the United States and Chinese companies, with an emphasis on expansion into China through market development and the establishment of satellite offices.
Accelerator
Incubator
Hanhai Plug and Play
China
Hanhai Plug and Play wass an accelerator that sought to invest in the educational services, media, entertainment, biotechnology and information technology sectors. The firm wass based in Zhegzhou City, China.
Accelerator
Incubator
Hans Back
Ireland
Mr. Colm Lyon is the Founder and serves as Chief Executive Officer at Fire Financial Services. He serves as Board Member at VT IoT. Mr. Colm also serves as Chief Executive Officer & is a Founder at Realex Payments. Colm has worked in financial services related businesses for over twenty five years, starting with fourteen years in the banking sector. He is a regular speaker at payments and internet industry events across Europe and frequently commentates for press as a payments expert and visionary about the future of money. He is passionate about "changing payments for the better". He has participated in and established several business associations. Most notably Colm was chairman of the Irish Internet Association, founder of the Internet Growth Alliance and more recently (2014) he founded the Payments Ireland networking group. He has served as a member of the Dublin Chamber of Commerce Council in 2014. Colm is a graduate of University College Dublin with a Bachelor of Commerce and a Master of Management Science Degree. Over the past few years he has spent further time in Harvard and Stanford Business School with the Leadership 4 Growth programme.
Individual/Angel
Hans Kupper
Munich, Bayern, Germany
Dr. Hans Kupper is a partner at Global Life Science Ventures since 1999. Dr Kupper has 29 years of experience in biotechnology with 19 years...
Investment Partner
HardGamma Ventures
Warsaw, Mazowieckie, Poland
HardGamma Ventures is a venture capital fund that invests in startups that focuses on computing, internet, biotechnology, and more.
Finance
Financial Services
FinTech
Venture Capital
Venture Capital
HardTech Labs
United States
HardTech Labs is an accelerator program that gives startups operating in the hardware and biotech sectors access to low-cost manufacturing. The firm was founded in 2014 and is based in Del Mar, California. It seeks to invest in the hardware, software or biotechnology products, sensors, diagnostics and medical devices firms.
Accelerator
Incubator
Harinderpal Hanspal
Seattle, Washington
Focus Areas: Manufacturing, Energy, Supply Chain, Transportation, Smart Buildings, SpaceTech, IoT, Industrial, Edge
Investors who were founders
Harry Hyman
United States
Dr. Una Ryan served as Managing Director at Golden Seeds. She is a Board Member of Cortexyme .She is currently Research Professor of Medicine at BU School of Medicine and serves on its Board of Visitors. Her board positions include AMRI (Lead Director, Nominating and Compensation committees) and MSH (Audit and Compensation committees). She was most recently President and CEO of Diagnostics For All (DFA), a non-profit organization developing inexpensive diagnostics for global health and agricultural uses. Previously, she was President and CEO of AVANT Immunotherapeutics, Inc, (NASDAQ) a company developing vaccines and immunotherapeutics for cancer, travellers, food safety and global health and also a member of its Board of Directors. Prior to AVANT, she was director of Health Sciences at Monsanto Company. Before that, she held a number of positions in academia, including Research Professor of Surgery at Washington University School of Medicine in St. Louis and Professor of Medicine at the University of Miami School of Medicine. She was also Chair of the Massachusetts Biotechnology Council, served on its Board, as well as the Biotechnology Industry Organization, New England Healthcare Institute, Board of Associates of the Whitehead Institute, Strategy and Policy Council of the MIT Center for Biomedical Innovation, Massachusetts Life Sciences Collaborative Leadership Council and the Goddard Council on science, technology, engineering and mathematics education. She holds a PhD in Cellular and Molecular Biology from Cambridge University and BS degrees in Zoology, Microbiology and Chemistry from Bristol University. She received an Honorary Doctor of Science degree from Bristol University in 2009. In 2007, she received the Albert Einstein Award for outstanding achievement in the life sciences. In 2002 Her Majesty Queen Elizabeth II awarded she the Order of the British Empire (OBE) for services to research, development and promotion of biotechnology. She is also an Angel Investor. She also served as a Board Member at EMulate Therapeutics.
Individual/Angel
Harry Welten
Switzerland, Europe
Harry has 20 years of international executive experience, more than 11 of which as a CFO in the biotech industry. Prior to joining Cytos, Mr...
Individual/Angel
Showing 501 to
520 of
1,117 results